Market Overview
The global Minimally Invasive Surgical Instruments and Accessories (MISIA) market was valued at USD 20.5 billion in 2024 and is projected to reach USD 28.52 billion by 2031, exhibiting a CAGR of 18.0% during the forecast period
USD 28.52 billion by 2031 USD 20.5 billion in 2024
of 18.0%
Laparoscopic Instruments
Endoscopic Instruments
Robotic Surgical Systems
Surgical Accessories
Robotic Surgical Systems represent the most technologically advanced segment, driving premium pricing and adoption in developed markets. Their integration with advanced imaging and haptic feedback systems creates significant competitive advantages for early adopters.
By Application
Cardiovascular Surgery
Orthopedic Surgery
Gastrointestinal Surgery
Neurological Surgery
Others
Cardiovascular applications continue to demonstrate the highest growth trajectory due to increasing cardiovascular disease prevalence and aging populations. The segment benefits from continuous technological advancements that reduce procedure times and improve patient outcomes across all healthcare settings.
Our Key Players
Medtronic plc (Ireland)
Johnson & Johnson (US)
Stryker Corporation (US)
Boston Scientific Corporation (US)
Abbott Laboratories (US)
CONMED Corporation (US)
Smith & Nephew plc (UK)
